Claire Stines-Chaumeil

Title: Claire Stines-Chaumeil: Innovator in Glucose Dehydrogenase Technology

Introduction

Claire Stines-Chaumeil is a prominent inventor based in Talence, France. She has made significant contributions to the field of biochemistry, particularly in the development of glucose electrodes. Her work is crucial for advancements in diabetes management and biofuel technology.

Latest Patents

Stines-Chaumeil holds a patent for "Mutants of pyrroloquinoline quinine-dependent soluble glucose dehydrogenase." This invention relates to novel mutants of PQQ s-GDH that contain an amino acid substitution in position 428 of the protein sequence of the wild type PQQ s-GDH. The patent outlines the use of these mutants for developing glucose electrodes, which are essential for glucose assays, especially in diabetic patients. Additionally, these mutants can be utilized in biofuel cells that use glucose as fuel.

Career Highlights

Claire Stines-Chaumeil is affiliated with the Centre National de la Recherche Scientifique, where she conducts her research. Her innovative work has garnered attention in the scientific community, contributing to advancements in glucose monitoring technologies.

Collaborations

Stines-Chaumeil collaborates with notable colleagues, including Nicolas Mano and Fabien Durand. Their combined expertise enhances the research and development of glucose-related technologies.

Conclusion

Claire Stines-Chaumeil is a key figure in the innovation of glucose dehydrogenase technology, with her patent paving the way for improved diabetes management and biofuel applications. Her contributions are vital to the ongoing advancements in these fields.